Skip to main content
AAWH
OTC Life Sciences

Ascend Wellness Settles Arbitration Award for $17 Million, Reducing Prior Liability

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare
Sentiment info
Neutral
Importance info
8
Price
$0.531
Mkt Cap
$107.425M
52W Low
$0.26
52W High
$1.2
52W Position info
104% above low
Off High info
56% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

AAWH has more than doubled off its 52-week low of $0.26.

Summary

Ascend Wellness Holdings, Inc. announced a settlement agreement to resolve a previously disclosed arbitration award, agreeing to pay $17.0 million, a reduction from the original $19.7 million award.


Key Events · Legal and Risk Events · AAWH

  • Arbitration Award Settled

    The company entered into a settlement agreement with Green Thumb Industries Inc. (GTI) to resolve the arbitration award previously disclosed on February 6, 2026.

  • Negotiated Payment Amount

    Ascend Wellness Holdings, Inc. agreed to a negotiated payment of $17.0 million to fully satisfy the award.

  • Reduced Financial Impact

    The settlement amount of $17.0 million is a reduction from the original net award of approximately $19.7 million, saving the company $2.7 million.

  • Claims Fully Resolved

    The Settlement Agreement resolves all claims asserted in the arbitration proceeding, and the company does not expect material disruption to operations.


Analysis · AAWH · Life Sciences

This 8-K filing provides an update to the previously disclosed arbitration award from February 6, 2026. The company has successfully negotiated a settlement, reducing the net payment from the original $19.7 million award to $17.0 million. While the $17.0 million payment represents a substantial cash outflow for the company, the $2.7 million reduction in liability is a positive development, mitigating some of the financial impact. The settlement resolves all claims related to the arbitration, removing a significant legal overhang.

At the time of this filing, AAWH was trading at $0.53 on OTC in the Life Sciences sector, with a market capitalization of approximately $107.4M. The 52-week trading range was $0.26 to $1.20. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

AAWH - Latest Insights

AAWH
Jul 09, 2026, 5:30 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $0.410
Real-time Price: $0.40625 info
Change: -$0.00375 (-0.91%) info
Market Cap: $82.483M info
AAWH
Jun 25, 2026, 4:43 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.4475
Real-time Price: $0.40625 info
Change: -$0.04125 (-9%) info
Market Cap: $82.483M info
AAWH
Jun 25, 2026, 4:42 PM EDT
Filing Type: PREM14A
Importance Score:
7
Price at Filing: $0.4475
Real-time Price: $0.40625 info
Change: -$0.04125 (-9%) info
Market Cap: $82.483M info
AAWH
May 13, 2026, 5:15 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.5699
Real-time Price: $0.40625 info
Change: -$0.16365 (-29%) info
Market Cap: $82.483M info
AAWH
May 13, 2026, 4:18 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.5699
Real-time Price: $0.40625 info
Change: -$0.16365 (-29%) info
Market Cap: $82.483M info